AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


When it comes to clinical laboratories, professionals should be aware of more than just performing tests. Being knowledgeable of budgets and finances plays a significant role in whether a clinical lab is seen as a profit center, rather than a cost center.
With testing in the global spotlight, two laboratorians share their stories of bringing up testing as regulatory hurdles, shortages of test components, and a rapidly expanding pandemic stressed laboratories unlike anything before.
With the advancement of next-generation sequencing based tests, clinical labs turn to bioinformatics pipelines to analyze and process data. When implementing bioinformatics pipelines, lab professionals must consider a variety of resources to ensure consistent efficiency.
Even as the cause of Parkinson’s disease remains elusive, the search is on for biomarkers that would enable earlier diagnosis of this debilitating movement disorder, track its progression, and support effective targeted therapies.

Ask the Expert

Bench Matters

Federal Insider

After a 1-year delay, Congress officially passed the Laboratory Access for Beneficiaries Act to improve the process of data collection for the Protecting Access to Medicare Act, which benefits senior patients.

Industry Playbook

Through a $50 million deal Veracyte acquires access to the NanoString Technology nCounter Analysis System to expand its diagnostics platform globally. The agreement allows Veracyte to use technology to advance genomic testing in hospitals and laboratories worldwide.

Regulatory Roundup

The Sample